Sustained adherence to ESC guideline‐recommended medications is associated with lower long‐term mortality in heart failure and reduced ejection fraction: Insights from the EPICAL2 cohort
Author:
Affiliation:
1. Université de Lorraine APEMAC Nancy France
2. CHRU‐Nancy INSERM Université de Lorraine Nancy France
3. CHRU‐Nancy Département Méthodologie Promotion Investigation Université de Lorraine Nancy France
Funder
Agence Nationale de la Recherche
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13176
Reference36 articles.
1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2. Heart failure: preventing disease and death worldwide
3. Nouvelle ère thérapeutique dans l’insuffisance cardiaque à fraction d’éjection réduite : quelle population de patients français cela concerne-t-il ?
4. First hospitalization for heart failure in France in 2009: Patient characteristics and 30-day follow-up
5. Two-year outcome of patients after a first hospitalization for heart failure: A national observational study
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Call for Action to Target Interhospital Variation in Cardiovascular Mortality, Readmissions, and Length-of-Stay;Medical Care;2024-05-21
2. Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF;ESC Heart Failure;2023-12
3. Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction;European Journal of Heart Failure;2021-12
4. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology;European Journal of Heart Failure;2021-05-20
5. Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management;Drug Design, Development and Therapy;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3